Посилання
- 1. Волкова М.А. (ред.) (2001) Клиническая онкогематология. Руководство для врачей. Медицина, Москва, 576 с.
- 2. Демина Е.А. (2004) Лимфома Ходжкина. Возможности современной терапии первичных больных. РМЖ, 12(19): 1113–1118 (http://www.rmj.ru/articles_183.htm).
- 3. Демина Е.А. (2006) Лимфома Ходжкина: прогностические признаки сегодня. Современная онкология, 8(4): http://www.consilium-medicum.com/magazines/special/cancer/article/8693.
- 4. Тумян Г.Н., Тупицын Н.Н., Пробатова Н.А., Ковригина А.М., Шолохова Е.Н., Демина Е.А. (2006) Иммунологические критерии прогноза при лимфоме Ходжкина. Современная онкология. Онкогематология, 8(1).
- 5. Behringer K., Diehl V. (2005) Twenty-five years clinical trials of the German Hodgkin Study Group (GHSG) Eur. J. Haematol., 75(Suppl. 66): 21–25.
- 6. Diehl V. (2002) From the tumor cell to the cure of Hodgkin’s Disease. Ann. Oncol., 13(Suppl. 2): 22.
- 7. Diehl V. (еd.) (1996) Bailliere’s Clinical Hematology, International Practice and Research: Hodgkin’s Lymphoma. Saunders, London.
- 8. Foss H.D., Marafioti T., Stein H. (2000) Hodgkin lymphoma. Classification and pathogenesis. Pathologe, 21(2): 113–123.
- 9. Gallamini A., Raviolo E., Merli F. et al. (2004) Predictive value of positron emission tomography (PET) performed after two cycles of standard chemotherapy on treatment outcome in Hodgkin disease. 6th International Symposium on Hodgkin’s lymphoma. Eur. J. Haematol., 73(Suppl 65): abstract D04.
- 10. Gisselbrecht C., Mounier N., André M. et al. (2005) How to define intermediate stage in Hodgkin’s lymphoma? Eur. J. Haematol., 75(Suppl. 66): 111–114.
- 11. Hasenclever D. (2002) The disappearance of prognostic factors in Hodgkin’s disease. Ann. Oncol., 13(Suppl. 1): 75–78.
- 12. Hasenclever D., Diehl V. (1998) A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease. N. Engl. J. Med., 339(21): 1506–1514.
- 13. Henry-Amar M., Aeppli D.M., Anderson J. et al. (1990) Workshop statistical report. In: R. Somers, M. Henry-Amar, J.H. Meerwaldt, P. Carde (Eds.) Treatment Strategy in Hodgkin’s Disease. Colloque INSERM. Vol. 196. London: John Libbey Eurotext, p. 169–418.
- 14. Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. (2001) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoitic and Lymphoid Tissues. IARC Press, Lyon.
- 15. Josting A., Rueffer U., Franklin J. et al. (2000) Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group. Blood, 96(4): 1280–1286.
- 16. Mauch P.V., Armitage J.O., Diehl V. et al. (eds.) (1999) Hodgkin’s disease. Lippincott Williams & Wilkins, Philadelphia, PA.
- 17. Miller T.P., LeBlanc M., Braziel RM.. et al. (2002) Was the bimodal age incidence of Hodgkin’s lymphoma a result of mistaken diagnoses of non-Hodgkin’s lymphoma? Blood 100: 3048.
- 18. Peckham M.J., Ford H.T., McElwain T.J. et al. (1975) The results of radiotherapy for Hodgkins’ disease. Br. J. Cancer, 32(3): 391–400.
- 19. Rueffer U., Sieber M., Josting A. et al. (1999) Prognostic factors for subdiaphragmatic involvement in clinical stage I-II supradiaphragmatic Hodgkin’s disease: a retrospective analysis of the GHSG. Ann. Oncol., 10(11): 1343–1348.
- 20. Spaepen K., Stroobants S., Dupont P. et al. (2001) Can positron emission tomography with [(18) F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin’s disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity? Br. J., Haematol., 115: 272–278.
- 21. Specht L. (1996) Prognostic Factors in Hodgkin’s Disease. Semin. Radiat. Oncol., 6(3): 146–161.
- 22. Weihrauch M.R., Re D., Scheidhauer K. et al. (2001) Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease. Blood, 98(10): 2930–2934.
Прогностические факторы течения лимфомы Ходжкина: настоящее и будущее
Резюме. В статье представлены современные взгляды на систему прогностических факторов при лимфоме Ходжкина. В историческом аспекте проведен анализ клинико-лабораторных и гистологических особенностей течения заболевания, определяющих его прогноз. Освещена роль новейших прогностических факторов, таких как позитронно-эмиссионная томография.
Ключевые слова: прогностические факторы, лимфома Ходжкина
Prognostic factors of clinical course of Hodgkin’s lymphoma: the present and the future
Summary. In the article the modern conception of system of prognostic factors in Hodgkin’s lymphoma are submitted. The analysis of clinical, laboratory and histopathologic features of clinical course, that determine prognosis for the disease, was made from the historical point of view. The role of the newest prognostic factors, such as positron emission tomography is covered.
Key words: prognostic factors, Hodgkin’s lymphoma